1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with Kidney Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE | 1 |
1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Kidney Neoplasms
Article | Year |
---|---|
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes | 2004 |